Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ehninger

Showing results (271-280 of 317) with videos related to

Pageof 32
Sort By:
Journal of Internal Medicine|April 24, 2012
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patientsO Ringdén, M Labopin, D W Beelen, et al.
Leukemia|September 3, 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialU Platzbecker, M Wermke, J Radke, et al.
Bone Marrow Transplantation|September 30, 2008
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumM von Bonin, F Stölzel, A Goedecke, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2004
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia IntergroupR F Schlenk, A Benner, J Krauter, et al.
Annals of Hematology|May 6, 2004
Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cellsM Bornhäuser, T Illmer, P Le Coutre, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Leukemia|March 10, 2001
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markersC Thiede, M Bornhäuser, U Oelschlägel, et al.
Journal of Internal Medicine|October 30, 2018
Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysisJ Canaani, E Beohou, M Labopin, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Pageof 32

Showing results (271-280 of 317) with videos related to

Sort By:
Pageof 32
Journal of Internal Medicine|April 24, 2012
Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patientsO Ringdén, M Labopin, D W Beelen, et al.
Leukemia|September 3, 2011
Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trialU Platzbecker, M Wermke, J Radke, et al.
Bone Marrow Transplantation|September 30, 2008
Treatment of refractory acute GVHD with third-party MSC expanded in platelet lysate-containing mediumM von Bonin, F Stölzel, A Goedecke, et al.
Leukemia|December 2, 2014
A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemiaS Piemontese, F Ciceri, M Labopin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 4, 2004
Individual patient data-based meta-analysis of patients aged 16 to 60 years with core binding factor acute myeloid leukemia: a survey of the German Acute Myeloid Leukemia IntergroupR F Schlenk, A Benner, J Krauter, et al.
Annals of Hematology|May 6, 2004
Imatinib mesylate selectively influences the cellular metabolism of cytarabine in BCR/ABL negative leukemia cell lines and normal CD34+ progenitor cellsM Bornhäuser, T Illmer, P Le Coutre, et al.
Leukemia|May 26, 2012
Phase IB study of the FLT3 kinase inhibitor midostaurin with chemotherapy in younger newly diagnosed adult patients with acute myeloid leukemiaR M Stone, T Fischer, R Paquette, et al.
Leukemia|March 10, 2001
Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem cell transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markersC Thiede, M Bornhäuser, U Oelschlägel, et al.
Journal of Internal Medicine|October 30, 2018
Trends in patient outcome over the past two decades following allogeneic stem cell transplantation for acute myeloid leukaemia: an ALWP/EBMT analysisJ Canaani, E Beohou, M Labopin, et al.
Blood Cancer Journal|July 30, 2016
Pretransplant NPM1 MRD levels predict outcome after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemiaS Kayser, A Benner, C Thiede, et al.
Pageof 32